Literature DB >> 22160488

Effect of the calcineurin inhibitor FK506 on K+-Cl- cotransporter 2 expression in the mouse hippocampus after kainic acid-induced status epilepticus.

Hyun Joo Shin1, Byeong Tak Jeon, Jungmee Kim, Eun Ae Jeong, Myeung Ju Kim, Dong Hoon Lee, Hyun Joon Kim, Sang Soo Kang, Gyeong Jae Cho, Wan Sung Choi, Gu Seob Roh.   

Abstract

Calcineurin (CaN)-mediated excitotoxicity impairs γ-aminobutyric acid (GABA) transmission and induces neuronal apoptosis. Ca(2+)-dependent K(+)-Cl(-) cotransporter 2 (KCC2) participates in GABAergic inhibitory transmission. However, the mechanism by which CaN mediates GABA receptor-mediated KCC2 in seizures is not fully understood. In the present study, we investigated the altered expression of KCC2 and the effects of the CaN inhibitor FK506 on KCC2 expression in the mouse hippocampus following kainic acid (KA) treatment. FK506 was injected twice 24 h and 30 min before KA treatment and then mice were treated with KA and killed 2 days later. FK506 had anticonvulsant effect on KA-induced seizure activities. CaN cleavage was evident in the hippocampus 24 h after KA treatment. FK506 pretreatment blocked the truncation of CaN in the KA-treated hippocampus. Cresyl violet and TUNEL staining showed that FK506 prevented KA-induced hippocampal cell death. In particular, Western blot analysis showed that KCC2 expression was time dependent, with a peak at 6 h and a return to decreased levels at 48 h, whereas FK506 pretreatment inhibited the KA-induced decrease in KCC2 expression in the hippocampus. Immunofluorescence showed that FK506 pretreatment protected the loss of inhibitory GABAergic KCC2-expressing neurons following KA treatment. Taken together, these results provide evidence that altered KCC2 expression may be associated with Ca(2+)-mediated seizure activity and indicate that neuron-specific KCC2 may be involved in neuroprotection after seizures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160488     DOI: 10.1007/s00702-011-0746-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  42 in total

1.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.

Authors:  H G Wang; N Pathan; I M Ethell; S Krajewski; Y Yamaguchi; F Shibasaki; F McKeon; T Bobo; T F Franke; J C Reed
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

Review 2.  Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death.

Authors:  M R Duchen
Journal:  J Physiol       Date:  1999-04-01       Impact factor: 5.182

3.  Seizure-induced glutamate release in mature and immature animals: an in vivo microdialysis study.

Authors:  Z Liu; C E Stafstrom; M R Sarkisian; Y Yang; A Hori; P Tandon; G L Holmes
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

4.  Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus.

Authors:  Yuto Ueda; Hidekatsu Yokoyama; Akira Nakajima; Jun Tokumaru; Taku Doi; Yoshio Mitsuyama
Journal:  Exp Brain Res       Date:  2002-09-25       Impact factor: 1.972

5.  In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons.

Authors:  S Pal; S Sombati; D D Limbrick; R J DeLorenzo
Journal:  Brain Res       Date:  1999-12-18       Impact factor: 3.252

6.  Phosphorylation of 14-3-3ζ at serine 58 and neurodegeneration following kainic acid-induced excitotoxicity.

Authors:  Eun Ae Jeong; Byeong Tak Jeon; Jeong Bin Kim; Joon Soo Kim; Yong Woon Cho; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Anat Cell Biol       Date:  2010-06-30

7.  Anticonvulsant activity of delta-HCH, calcium channel blockers and calmodulin antagonists in seizures induced by lindane and other convulsant drugs.

Authors:  J M Tusell; S Barrón; J Serratosa
Journal:  Brain Res       Date:  1993-09-17       Impact factor: 3.252

8.  Neuroprotective action of FK-506 (tacrolimus) after seizures induced with pilocarpine: quantitative and topographic elemental analysis of brain tissue.

Authors:  Joanna Chwiej; Krzysztof Janeczko; Marianna Marciszko; Mateusz Czyzycki; Karen Rickers; Zuzanna Setkowicz
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

Review 9.  Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction and calcineurin activation.

Authors:  Hiroyuki Uchino; Yasuhiro Kuroda; Saori Morota; Go Hirabayashi; Nagao Ishii; Futoshi Shibasaki; Yukiho Ikeda; Magnus J Hansson; Eskil Elmér
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

10.  Involvement of calcineurin in glutamate-induced mitochondrial dynamics in neurons.

Authors:  Xiao-Jian Han; Yun-Fei Lu; Shun-Ai Li; Kazuhito Tomizawa; Kohji Takei; Masayuki Matsushita; Hideki Matsui
Journal:  Neurosci Res       Date:  2007-10-13       Impact factor: 3.304

View more
  4 in total

1.  Tonicity-responsive enhancer binding protein haplodeficiency attenuates seizure severity and NF-κB-mediated neuroinflammation in kainic acid-induced seizures.

Authors:  H J Shin; H Kim; R W Heo; H J Kim; W S Choi; H M Kwon; G S Roh
Journal:  Cell Death Differ       Date:  2014-03-07       Impact factor: 15.828

Review 2.  Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.

Authors:  Tarek Z Deeb; Jamie Maguire; Stephen J Moss
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

3.  Use of FK506 and bone marrow mesenchymal stem cells for rat hind limb allografts.

Authors:  Youxin Song; Zhujun Wang; Zhixue Wang; Hong Zhang; Xiaohui Li; Bin Chen
Journal:  Neural Regen Res       Date:  2012-12-05       Impact factor: 5.135

4.  Atorvastatin pretreatment attenuates kainic acid-induced hippocampal neuronal death via regulation of lipocalin-2-associated neuroinflammation.

Authors:  Zhen Jin; Yohan Jung; Chin-Ok Yi; Jong Youl Lee; Eun Ae Jeong; Jung Eun Lee; Ki-Jong Park; Oh-Young Kwon; Byeong Hoon Lim; Nack-Cheon Choi; Gu Seob Roh
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.